The Pig-a assay is used for monitoring somatic cell mutation in laboratory animals and humans. The assay detects haematopoietic cells deficient in glycosylphosphatidylinositol (GPI)-anchored protein surface markers using flow cytometry. However, given that synthesis of the protein markers (and the expression of their genes) is independent of the expression of the X-linked Pig-a gene and the function of its enzyme product, the deficiency of markers at the surface of the cells may be caused by a number of events (e.g. by mutation or epigenetic silencing in the marker gene itself or in any of about two dozen autosomal genes involved in the synthesis of GPI). Here we provide direct evidence that the deficiency of the GPIanchored surface marker CD48 in rat T-cells is accompanied by mutation in the endogenous X-linked Pig-a gene. We treated male F344 rats with N-ethyl-N-nitrosourea (ENU), and established colonies from flow cytometry-identified and sorted CD48-deficient spleen T-lymphocytes. Molecular analysis confirmed that the expanded sorted cells have mutations in the Pig-a gene. The spectrum of Pig-a mutation in our model was consistent with the spectrum of ENU-induced mutation determined in other in vivo models, mostly base-pair substitutions at A:T with the mutated T on the non-transcribed strand of Pig-a genomic DNA. We also used next generation sequencing to derive a similar mutational spectrum from a pool of 64 clones developed from flow-sorted CD48-deficient lymphocytes. Our findings confirm that Pig-a assays detect what they are designed to detect-gene mutation in the Pig-a gene.
Introduction
The flow cytometry-based assay for measuring somatic mutation in the endogenous X-linked Pig-a gene of rodents (and the PIG-A gene of humans) is useful in basic research as well as in regulatory safety evaluations, i.e. for identification of genotoxic hazards (potential carcinogens) and risk assessment (1) . The human and rodent Pig-a assays are based on the genetics of glycosylphosphatidylinositol (GPI) biosynthesis, which was elucidated in depth from understanding the molecular nature of a rare human acquired genetic disorder, paroxysmal nocturnal haemoglobinuria (PNH). GPI is an anchor tethering a number of specific protein markers at the exterior surface of the cytoplasmic membrane. In PNH patients, a fraction of bone marrow stem cells has inactivating mutations in the single functional copy of the X-linked PIG-A gene, which disrupts the synthesis of GPI (2) (3) (4) . PIG-A mutant stem cells produce differentiated peripheral blood cells that are deficient in GPI anchors, and, consequently, are deficient in surface-bound marker proteins. The biology of GPI synthesis and the anchoring of markers is evolutionally conserved in humans and laboratory animals (5); as a result, Pig-a assays can be designed for multiple species using methodologies similar to the one employed for the diagnosis of PNH (6) . Most assays are performed on haematopoietic tissue (bone marrow or peripheral blood), and they are based on the detection of cells deficient in surface-bound protein markers (presumed Pig-a mutants) using a variety of flow cytometry analyses.
The research and regulatory communities have paid increased attention to the assay due to its relative simplicity, low background mutant frequency, good reproducibility, portability and cumulative response to repeated treatments with prototypical mutagens (1, 7, 8) . Currently, the red blood cell (RBC)-based assay is of particular interest due to its ability to measure a relevant end-point (i.e. gene mutation) and its potential to be incorporated into the standard repeated-dose toxicology safety evaluations (as discussed at the International Workgroup on Genotoxicity Testing meeting in October 31-November 1, 2013, Foz do Iguacu, Brazil; the expert workgroup report is due in 2014).
However, only circumstantial evidence supports the presumption that the flow cytometry-based Pig-a assay measures mutation in the Pig-a gene. The data from PNH patients and theoretical considerations suggest that, in rodents treated with mutagens, GPI-anchored marker deficiency should be equivalent to Pig-a mutation, but direct confirmation of this has been insufficient. Miura et al. determined the spectrum of N-ethyl-N-nitrosourea (ENU)-induced Pig-a mutation in rat lymphocytes, although the mutant T-cells were detected not by flow cytometry but by resistance to proaerolysin in limiting dilution cultures (9, 10) . Kimoto et al. (11) sorted out GPI-anchored marker-deficient mouse erythroid precursor cells from bone marrow and demonstrated that Pig-a mutant alleles were present in the pool of cells. However, in this latter approach, there was no direct link made between a specific marker-deficient cell and a particular Pig-a mutation (among a very limited number of sequenced Pig-a cDNA variants).
In the present study, we established a direct connection between the flow cytometry-identified GPI-anchored marker-deficient phenotype and Pig-a mutation in individual spleen T-lymphocytes. If such a link can be proven unambiguously for T-cells, then it would support the assertion that a similar relationship is valid for other cell types, e.g. RBCs. Also, we explored the usefulness of next generation sequencing (NGS) technology as an alternative tool for the rapid identification of Pig-a mutation spectra in a complex mixture of flow-sorted Pig-a mutant phenotype T-lymphocytes.
Materials and methods

Animals and ENU treatment
All animal procedures were reviewed and approved by the NCTR Institutional Animal Care and Use Committee. At 6-7 weeks of age, 16 F344 male rats were treated every other day with a total of three doses of 40 mg/kg ENU (Sigma-Aldrich, St Louis, MO, USA), for a cumulative dose of 120 mg/kg. An ENU stock containing 4 mg of active ingredient per each millilitre was prepared fresh for each treatment in the vehicle, Dulbecco's phosphate-buffered saline (DPBS; Invitrogen, Carlsbad, CA, USA), adjusted to pH6 with hydrochloric acid. The stock solution was delivered promptly to the animals by gavage. Four control animals were treated concurrently with similar volumes of the vehicle.
RBC Pig-a assay
Twenty-eight days after the last ENU gavage, the basic RBC Piga assay was performed as previously described (12) with minor modifications to take advantage of recently available allophycocyanin (APC)-conjugated HIS49 and r-phycoerythrin (PE)-conjugated anti-rat CD59 antibodies (BD Biosciences, Milpitas, CA, USA). Approximately 150 μl of peripheral blood were collected from the tail vein into a 1 ml syringe equipped with a 25 Ga needle and expelled into a 1.5 ml microcentrifuge tube; promptly, 100 μl of that blood were mixed in a separate tube with 100 μl of anticoagulant heparin solution [500 USP/ml; made from powdered heparin (Sigma) and DPBS, pH 7] . The labelling and flow cytometry procedures used neutral DPBS supplemented with 2% heat inactivated fetal bovine serum (FBS; Atlanta Biologicals, Lawrenceville, GA, USA). Anticoagulant-preserved blood (6 μl) were mixed with 190 μl of DPBS/FBS, 0.5 μl of APC-conjugated HIS49 anti-erythroid antibody (BD), 4 μl of PE-conjugated anti-rat CD59 antibody (BD), and incubated for 30 min at room temperature in the dark. Following incubation, the labelling reactions were centrifuged for 3 min at 300×g, the supernatants were aspirated, and the cell pellets were resuspended in 500 μl of DPBS/FBS. The washed samples were processed on a FACSAria I flow cytometer (BD) equipped with 488 nm blue and 633 nm red excitation lasers. Pig-a mutant phenotype RBCs were identified as HIS49-positive and CD59-negative cells. The gate for single-cell CD59-negative mutants was determined by running a concurrently prepared mutant-mimic control sample-the blood labelled with APC-HIS49 only (cytograms for the RBC Pig-a assay are not shown).
Spleen T-lymphocyte labelling and analysis
Spleen lymphocyte analysis was performed on groups of 2-4 animals per day (at approximately weekly intervals, starting at Day 31 after the last gavage and continuing to Day 60). Animals were euthanised by CO 2 . Using aseptic techniques, spleens were extracted from the animals and the cells were released as previously described (13) . Briefly, the spleens were cut into four pieces, each piece was crushed with the serrated butt end of a 10 ml syringe plunger in 3 ml of RPMI1640 medium (Invitrogen) in a separate well of a 12-well tissue culture plate; the cell clumps were broken up by aspirating the suspension through a 25 Ga needle into a 10 ml syringe, and the resulting cell suspension was loaded onto 3 ml of Lympholyte™-R (Cedarlane, Burlington, NC, USA) in a 15 ml tube (for a total of four tubes per spleen). The density gradient tubes were centrifuged for 20 min at 1500×g; the fractions of mononuclear cells belonging to the same animal were combined in a 50 ml tube and washed with 35-40 ml of RPMI1640 and centrifuged for 10 min at 800×g. The cell pellets were resuspended in 5 ml of ice cold 1× RBC lysis buffer prepared from 10× concentrate (BioLegend, San Diego, CA, USA) and incubated on ice for 5 min. The lysis buffer was diluted by adding 30 ml of DPBS/ FBS and removed by centrifugation for 5 min at 340×g. Then the pellet was washed again with10 ml DPBS/FBS and centrifugation. Finally, the RBC-free cells were resuspended in 2 ml of DPBS/FBS and passed into a fresh 50 ml tube through a 70 μm cell strainer (Falcon, Tewksbury, MA, USA). The concentration of cells (usually in the range of 20-30 × 10 6 /ml) was determined using a Coulter counter (Beckman Coulter, Indianapolis, IN, USA). The standard labelling reactions in 1.5 ml tubes consisted of 100 μl of cells, 100 μl of DPBS/FBS, 3 μl of PE-conjugated anti-rat CD48 (BioLegend), and 3 μl of APC-conjugated anti-rat T-cell receptor (TCR) αβ (BioLegend). After a 30-min incubation on ice, the cells were centrifuged for 3 min at 300×g. The pellets were resuspended in 500 μl of DPBS/FBS, combined with 20 μl of 7AAD viability stain (BD), and filtered into 5 ml flow tubes through 35 μm strainer caps (Falcon). The tubes were stored on ice until ready for analysis on the FACSAria I flow cytometer. CD48-deficient, presumably Pig-a mutant, viable T-lymphocytes were identified as 7AAD-negative, APC-positive and PE-negative. The gate for mutant cells was determined by analysing a mutant-mimic control sample-cells labelled with all the reagents excepting anti-CD48 antibody (Figure 1 ). 
Immunomagnetic enrichment for Pig-a mutant lymphocytes
For magnetic enrichment, the standard labelling reactions (as described above) were scaled up 10-fold in 15 ml tubes. After incubation on ice for 30 min, the labelled cells were washed with 10 ml DPBS/FBS, centrifuged for 5 min at 340×g, and the pellets were resuspended in 500 μl DPBS/FBS. For mutant enrichment, 50 μl of anti-PE superparamagnetic microbeads (Miltenyi, Auburn, CA, USA) were added to the antibody-labelled cells, and the suspension was incubated on ice for 20 min, then washed with 10 ml of DPBS/ FBS, centrifuged for 5 min at 340×g, resuspended in 2 ml DPBS/FBS, and loaded on an LS MACS separation column (Miltenyi) mounted on a Quadro MACS magnet (Miltenyi). Before loading the cells, the columns were washed and pre-wetted on the magnet with 3 ml of DPBS/FBS. The pass-through fraction of CD48-deficient cells was collected into a 15 ml tube; while still on the magnet, the columns were washed with an additional 5 ml of DPBS/FBS and the eluate was collected into the same 15 ml tube. The resulting 7 ml of eluted cells were centrifuged for 5 min at 340×g, and the invisible cell pellet was resuspended in 1 ml of DPBS/FBS; 40 μl of 7AAD were added to the cells and the suspension was filtered through 35 μm strainer caps into 5 ml flow tubes. The samples were stored on ice until ready for sorting on the FACSAria flow cytometer ( Figure 1 ).
Cell sorting and culturing
The FACSAria cytometer setup and sorting were performed according to manufacturer's instructions. The cytometer was equipped with a 70 μm nozzle and operated at a sheath pressure of 70 psi (70/70 configuration). CD48-deficient T-lymphocytes from the appropriate gate were sorted into 96-well plates at four cells per well using the 'single-cell' precision sorting mode. The wells of the 96-well plates were pre-filled with 200-300 μl of lymphocyte growth medium (13) supplemented with 10% T-Stim (BD), 0.25 μg/ml ionomycin (Sigma), and 10 ng/ml phorbol myristate acetate (Sigma). In some cases, the wells contained 1000 feeders, spleen cells lethally irradiated with 20 Gy using an X-ray source (RS2000 irradiator; Rad Source Technologies, Atlanta, GA, USA).
Characterisation of clones formed by sorted cells
After sorting, the cells were allowed to grow for 7-9 days in a humidified incubator at 37°C in the presence of 5% CO 2 . During this period, the plates were inspected with an inverted tissue culture microscope for clonal expansion ( Figure 2 ). A few well-expanded clones (as in the top left, Figure 2 ) were analysed by flow cytometry. The clones were transferred from the wells into 1.5 ml tubes containing 500 μl of DPBS/FBS. The tubes were centrifuged for 3 min at 300×g, the pellets were suspended in 100 μl of antibody cocktail (96 μl of DPBS/ FBS, 2 μl of PE anti-CD48 and 2 μl of APC anti-TCR), and the tubes were incubated on ice for 30 min. After centrifugation for 3 min at 300×g, the cell pellets were resuspended in 250 μl DPBS/FBS, mixed with 10 μl of 7AAD, filtered through 35 μm strainers and analysed on the FACSAria using the same cytometer settings and gating as for the standard labelling and analysis ( Figure 1 ). For the purpose of molecular analysis, expanded clones were visually graded by size (as small or large), transferred into 1.5 ml tubes, and washed with 500 μl DPBS (without serum). The tubes were centrifuged for 3 min at 500×g, the supernatants were aspirated and the cell pellets either were stored at −80°C or processed for RNA extraction immediately. 
Analysis of Pig-a mutations using Sanger sequencing
A column-based RNeasy mini kit (Qiagen, Valencia, CA, USA) and QIAshredder columns were used to prepare total RNA from clones, generally following the manufacturer's suggested protocol. In the final step, RNA was eluted in 30 μl of RNase-free water and stored at −80°C.
Pig-a reverse transcription, cDNA amplification and amplification of nested fragments was performed as previously described (9,10) with minor modifications (i.e. some primers were redesigned for a more robust amplification; see Figure 3 ). Singlestranded Pig-a cDNA was synthesised using 5 μl of total RNA extracted from expanded clones, a Pig-a-specific reverse transcription primer RT1 (5′-AAGACCCAGAAACATTG) instead of oligodT primer and a High Capacity cDNA RT kit with MultiScribe RT enzyme (both from ABI/Invitrogen) in a final volume of 10 μl and a temperature profile: 48°C × 1 min + 42°C × 60 min + 4°C soak. 2 μl of the cDNA were employed for the first round amplification in a final volume of 22 μl using the components of the EncycloPCR kit (EvroGen, Moscow, Russia), Pig-a-specific primers R1151 (5′-ACATTTGGCCTTTCAGCACC) and F25 (5′-AGGCTTGCTCTGAGAACTGA), and a temperature profile: 95°C × 90 s + (95°C × 20 s + 58°C × 20 s + 72°C × 2 min) × 30 + 4°C soak. The first round PCR product was diluted 100-fold with water and used to amplify four nested fragments as described by Miura et al., with the exception that the new F25 primer was used instead of the old 1F primer. Nested PCR products were analysed for size by conventional agarose gel electrophoresis and prepared for sequencing with Qiagen's QIAquick PCR purification kit (either in a single-sample format or in a 96-well format). The purified products were sequenced using BigDye® Terminator chemistry on a 3130xl Genetic Analyzer (both from ABI). Identification of mutations was performed using SeqScape v2.5 software (ABI); the reference sequence was the same as previously reported (9) .
Analysis of Pig-a mutations using NGS
Pig-a mutations in 64 lymphocyte clones derived from ENU-treated animals #7 and #8 were analysed by NGS. First, 1 μl of singlestranded cDNA from each of these 64 clones was amplified individually using Pig-a-specific primers F25 and R1151 as described above, but with 40 thermal cycles. Each PCR reaction yielded similar amounts of amplified products, though a mixture of multiple fragments (including a band corresponding to the ~1.5 kb full-size presumed Pig-a product) was present in each tube. Then, all amplified samples were pooled together and processed on a single Qiagen QIAquick PCR purification column. The subsequent library preparation, amplification, processing on the instrument and analysis were performed according to Roche 454 GS Junior (Branford CT) instructions for unidirectional sequencing using the Lib-L protocol. Briefly, 500 ng of the pooled amplified Pig-a cDNA were sheared by nebulisation to generate fragments smaller than 1000 bp. These fragments were then end-repaired and ligated with the Roche 454 universal Rapid Library adaptors. The library was quantified and the sizes of DNA inserts were verified on an agarose gel as suggested in the Rapid Library Preparation Protocol Manual for the GS Junior instrument. The library was then diluted to 1 × 10 7 molecules/μl and used as a template for emulsion PCR (emPCR Amplification Method Manual-Lib-L for GS Junior) with primers and beads provided in the Lib-L kit. The resultant DNA-coated beads were combined with the sequencing primer (from the Lib-L kit) and loaded onto a GS Junior with all the necessary sequencing reagents. The data from a single run was compared to the entire rat genome and to the open reading frame (ORF) of the rat Pig-a cDNA reference sequence using the GS Reference Mapper software (Roche) under default settings.
Results
Induction of Pig-a mutations with ENU treatment
On Day 28 after the last ENU treatment, a basic RBC Pig-a assay was performed on all animals in order to identify the ones that were affected by ENU the most; i.e. those were deemed more likely to have mutation in the Pig-a gene of lymphocytes. All ENU-treated animals had significantly elevated frequencies of CD59-deficient RBCs, while the frequency of Pig-a mutant RBCs in control animals was low (see Table 1 ). Only half of the treated and control animals were used for subsequent lymphocyte analyses.
Direct comparison of the frequency of CD48-deficient, presumably Pig-a mutant, T-lymphocytes in control and ENU-treated animals on the same day (Day 45 after the last treatment) was performed using only two ENU-treated (#5 and #6) and two control animals (#17 and #18). With the gating strategy chosen for identification of mutants, the absolute response to ENU treatment in lymphocytes was less pronounced than in RBCs, with the frequencies of mutant T-cells [determined as the ratio (Mutant T-cells)/(TCR positive)] Note that only half of the animals (#1 through #8) were used for lymphocyte sorting, these provided sufficient number of mutant clones for sequencing analysis and determining ENU-induced Pig-a mutation spectrum.
a The RBC assay was performed on all animals 28 days after the last ENU gavage. b The T-cells assays were performed after the last ENU gavage on the days mentioned in the text. , respectively. In addition to these four animals, the frequency of CD48-deficient lymphocytes was determined on various days for animals #1 (54 × 10 −6 , Day 32), #2 (81 × 10 −6 , Day 32), #3 (106 × 10 −6 , Day 39). For other animals, the spleen cells were used only for the enrichment protocol and sorting.
Sorting and expansion of mutant cells
Magnetic column-based enrichment did not eliminate all CD48-positive wild-type (WT) cells from the samples but significantly reduced their numbers, increasing the ratio (Mutant T-cells)/(TCR positive) in ENU-treated animals from an average of ~70 × 10 −6 before the enrichment to ~5 × 10 −2 to ~1 × 10 −3 after the enrichment, resulting in an estimated enrichment of up to 100× (see Figure 1) .
After 7-9 days of incubation, the appearance of clones developed from sorted cells varied significantly-from no evidence of growing cells to a very large number of proliferating cells (estimated at several thousands of cells per well, see Figure 2 for representative photographs). The largest clones had a sufficient number of cells for subsequent reanalysis by flow cytometry (Figure 1 ), but their labelling profile (i.e. CD48 surface expression) did not necessarily match the properties of the sorted spleen T-cells (which were presumably CD48-negative). All the flow cytometry-analysed clones were derived from the animal #3.
Expansion of clones was more obvious on 96-well plates without irradiated feeder cells, where small clones of a dozen or so cells could be visualised clearly. On these plates, it was apparent that cell growth (ranging from minimal to robust) occurred in almost all wells seeded with 4 sorted cells.
Molecular analysis of mutant clones
For detecting sequence alterations in the Pig-a gene, 118 large clones (estimated to have >100 cells) were selected from 96-well plates seeded with CD48-deficient lymphocytes from eight animals (#1 through #8). Several criteria were used to classify the clones as potentially having a mutation: (i) a clear single base-pair substitution in one of the nested amplified Pig-a cDNA fragments, (ii) evidence of two basepair substitutions, e.g. two places within cDNA with the presence of a peak corresponding to a mutant allele and an equally strong peak corresponding to the WT-allele in the same position, (iii) amplification of nested fragments of different sizes, most likely caused by alternative splicing (sometimes confirmed by alternative sequences at exon-exon junctions within the Pig-a cDNA), (iv) a failure to amplify one or several nested cDNA fragments (possible deletions) and (v) an abrupt change in the fidelity of sequencing output data occurring at the exon-exon junctions (as evidence of a mixture of two fragments, one of which may be a product of alternative splicing).
Using these criteria, evidence of one or more mutation(s) was found for 105 clones; in the 13 remaining clones the sequence matched WT Pig-a cDNA. Of the 105 clones with mutations, 10 had potential deletions; insertions of G were found at two different sites (potential frameshifts); 14 clones had evidence of alternative splicing, most likely caused by point mutations at splice sites (for two clones, a mutation at A:T of the donor splice site was confirmed by sequencing); and 82 base-pair substitutions were identified. Seventy base-pair substitutions were unambiguous single mutations found in the clone. If all alternative splicing-type mutations were caused by point mutations at the splice sites, then the total number of point mutations in these 105 clones may be as high as 94 (of which 84 were determined by sequencing). Out of the 84 sequenced mutations, 70 were at A:T base pairs with the T on the non-transcribed strand of genomic DNA; mutations at G:C base pairs occurred when the C was on the non-transcribed strand.
Animal #7 contributed approximately half of all clones used for molecular analysis. Base-pair substitutions in Pig-a cDNA were found in all 8 processed ENU-treated animals. Point mutations at certain positions were found in several animals (potential hot spots), while some mutations were found repeatedly in clones derived from the same animal (potential in vivo clonal expansion of mutants). All but one identified base-pair substitution resulted in either an amino acid change, a disruption of initiation of translation (mutation within the first codon), or the premature termination of translation. The spectrum of independent Pig-a gene mutations (base-pair substitutions and frameshifts) is shown in Table 2 . The complete characterisation and classification of all analysed clones can be found in Supplementary Table I, available at Mutagenesis Online. a Determined with the total of 71 independent Pig-a mutations determined in 8 animals (#1 to #8) using Sanger sequencing. If the same mutation was found in 2 or more animals, it was considered as 2 (or more) independent mutations; if the same mutation was found in an animal several times, it was considered as one independent mutation. b Determined in this study using clones from animals #7 and #8 only. With NGS, the same mutation occurred in two animals can be counted as independent mutation only once. The total of 37 independent mutations were identified using 1% threshold for mutant frequency reads (see Figure 4 for details); these include 4 mutations that were not found using clone-by-clone Sanger sequencing. 
Analysis of mutations using NGS
In order to test the usefulness of NGS for the rapid analysis of mixtures of mutant alleles, we amplified the Pig-a cDNA of 64 clones (clones 401-464, all from animals #7 and #8; see Supplementary Table  I, available at Mutagenesis Online), pooled the amplified products together and performed unidirectional sequencing using the Roche 454 GS Junior NGS system. Overall, 26 918 068 bases were sequenced in 93 832 reads, and 75% of these reads mapped to the rat Pig-a gene when aligned against the rat genome. On average, each base of the Pig-a ORF was sequenced 11 875 times. The estimated error rate in our experiment using sequencing data for a standard reference DNA fragment was 0.63%, but we used a more conservative 1% cut-off rate for identifying mutations as literature suggests that unidirectional pyrosequencing produces random errors at any base with an average frequency of ~1% (15) . If an altered base was repeated in >1% of reads covering a specific position, then it was considered a bonafide mutation (rather than a random error of sequencing). We detected 37 mutations that met such criteria. Out of these, 33 were catalogued by Sanger sequencing and 4 were unique to this NGS approach. Seven mutants that were present in the mixture (as determined by Sanger sequencing of individual clones) were not detected by NGS using the 1% cut-off approach (see Figure 4 and Table 2 ).
Discussion
The objective of the present study was to determine whether CD48-deficient lymphocytes extracted from rats treated with a mutagen have mutations in the endogenous X-linked Pig-a gene, and if they do, to determine whether the spectrum of induced mutations is consistent with the known properties of that mutagen. For this purpose we treated F344 male rats with ENU and labelled their spleen cells with antibodies against the T-cell receptor and against CD48, a ubiquitous GPI-anchored lymphocyte cell surface marker. Then, using a fluorescence-activated cell sorter, we sorted CD48-deficient T-cells at low density into 96-well tissue culture plates and allowed the sorted cells to form clones without any selecting agent. Finally, we identified and characterised mutations in the Pig-a gene of the expanded clones. Figure 4 . Identification of Pig-a mutations in a mixture of CD48-deficient clones using NGS. Each vertical bar represents the fraction of reads with a mutation at a specific location on the Pig-a ORF out of all reads covering this particular location. Dashed line shows an empirical 1% cut-off level. The 564 bp position of the Pig-a ORF which is represented by a bar marked with (*) had a coverage of 9621 reads; in 8744 reads (~91%) WT T was encountered, in 877 reads (9.1%) a substitution to G was encountered, which was considered a legitimate mutation. The same mutation was found in 3 clones using Sanger sequencing. Mutations identified both by NGS and Sanger sequencing are shown as blue bars (33 mutations). All other NGS-identified Pig-a sequence alterations are shown as red bars; four sequence alterations exceeded the 1% threshold but were not found using Sanger sequencing. These 4 alterations occurred in positions that would result in termination of translation or amino acid substitutions in the Pig-a enzyme, and therefore may represent genuine Pig-a mutations. The remaining NGSidentified deviations from the reference Pig-a cDNA sequence may be random sequencing errors or legitimate mutations with poor expression of mRNA (or from poorly expanded clones). Seven mutations identified by Sanger sequencing were not detected by NGS using a 1% threshold.
Sorting and in vitro expansion of rare populations of primary cells is not novel per se; but, in the case of CD48-deficient (presumed Pig-a mutant) lymphocytes, we had to overcome several challenges. The elevated frequencies of CD48-deficient lymphocytes in animals treated with even a powerful mutagen like ENU are still much lower than what is considered a rare population in conventional flow cytometry (where 1% is a rare population). Though such infrequent CD48-deficient T-cells can be reliably counted on modern high-throughput flow cytometers, sorting individual mutants directly from labelled spleen mononuclear cells is problematic. It is impossible to achieve the desired sorting purity (i.e. single-cell sorting) using concentrated samples due to the high density of non-target cells in the stream and with dilution (to reduce the overall density of cells), it would require unrealistically long processing times for a single sample. In order to enrich splenocyte mixtures for mutant lymphocytes we employed a protocol that depleted the samples of CD48-positive WT cells, similar in principle to one described for high throughput RBC and reticulocyte Pig-a assays (16) . In a typical experiment, approximately one half of the cells extracted from one spleen was labelled with antibodies and beads, and then processed on a magnetic column, yielding up to a 100-fold enrichment of CD48-deficient cells. The resulting enriched samples could be processed on a FACSAria I sorter in 20-30 min, with a large fraction of the mutant cells successfully sorted out.
The viability of sorted lymphocytes remained high despite the fact that the antibodies used in the labelling reactions contained toxic sodium azide preservative and the sorting itself was performed at a relatively high pressure and using a small nozzle. Even though our FACSAria was not decontaminated or otherwise sterilised for aseptic sorting, we did not experience problems with bacterial or fungal contamination in sorted wells. Some clones expanded tremendously, and viable cells could be observed to some degree in almost all wells. We assume that the likelihood of two (or more) sorted cells contributing to larger clones is substantial; the sequencing data and flow reanalysis of select clones supports the conclusion that some wells contained a mixture of clones.
Surprisingly, despite the fact that parental CD48-deficient T-cells (that subsequently produced clones) were sorted from the same 'Mut T-cells' gate, the cells from the most vigorously expanded clones were 100% TCR-positive but had variable levels of CD48 surface expression, ranging from a clearly 'negative' to a fairly 'positive' WT-like phenotype (see Figure 1 ). There may be several explanations for this observation. First, sorting is not a 100% accurate and efficient process, and occasionally a CD48-positive cell may be sorted erroneously. Second, the gate for mutant cells in this study was determined with the help of a mutant-mimic control (cells prepared without PE anti-CD48), which may not adequately reflect the range of mutant phenotypes for the CD48-negative cell population. Using an appropriate fluorescent isotype control antibody to prepare the mutant-mimic control may alter the 'Mut T-cells' gate to match the population within the dashed oval appearing on the enriched sample cytogram ( Figure 1D ). In this case, more 'mutants' will be determined in the standard T-cell Pig-a assay, and the background (spontaneous) frequency of CD48-deficient cells in control animals may increase. A better, more specific anti-CD48 monoclonal antibody also may make the lymphocyte Pig-a assay more accurate and quantitative. The benefit of utilising a similar isotype control antibody in other varieties of the Pig-a assay (including the RBC Pig-a assay) remains to be determined.
Also, it appears that lethally irradiated feeder cells are not required for supporting the growth of sorted T-cells. The presence of non-viable feeder cells obscured visualisation of small and moderate clones in 96-well plates. In the present study, the formulation of the growth medium and using anti-TCR antibody provided sufficient mitogenic stimulation for the sorted cells.
In our study, at least eight of the point mutations identified within the Pig-a cDNA and three mutations affecting splicing were at the same sites as previously identified in proaerolysin-resistant lymphocytes (10) . The overall spectrum of Pig-a base-pair substitution in flow cytometry-identified mutants was very similar to the spectrum of Pig-a mutations identified by proaerolysin resistance, and the spectrum of mutations in the rat Hprt gene, with all three being highly specific for ENU-mostly mutations at A:T base pairs with the T on the non-transcribed strand (see Table 2 ). These data provide strong evidence of a linkage between CD48 deficiency, GPI anchor deficiency and mutation in the Pig-a gene of T-lymphocytes from ENU-treated rats.
Of particular interest are the several clones in which no mutations were identified. It must be noted that our sequencing did not cover the 5′ untranslated region or introns of the Pig-a gene. It is possible that we missed mutations in regulatory regions that might affect the efficiency of translation. Another possibility is that some clones may be a mixture of up to four independent sorted mutant cells. If these contained point mutations, then the resultant mixture of four cDNAs may not have produced mutant alleles distinguishable by Sanger sequencing. Sorting only one mutant cell per well could provide a cleaner, unambiguous sequencing chromatogram for the resultant clone. However unlikely, mutations in other autosomal genes (e.g. in other genes of the GPI synthesis pathway or in the gene encoding CD48) could result in CD48-deficient clones. We expect that such clones would be rare and may not account for the number of (presumably) CD48-deficient clones with a Pig-a WT genotype given the overall sample size. In any case, for the aims of this study, the finding that the majority of clones derived from sorted CD48-deficient cells contained Pig-a mutations support a strong relationship between the CD48-deficient phenotype and the Pig-a mutant genotype.
A few clones deemed to be deletions (those that failed to amplify several nested Pig-a fragments) may not be reliably classified as such, because the quality of RNA extracted from the clones may affect all downstream steps of the mutation analysis. We noted that frozen preserved clones more often produced 'deletion' mutants than the freshly processed clones, so it is possible that the RNA of some clones was degraded during freezing/storage/thawing. Overall, the protocol for sorting and molecular analysis can be further improved for more accurate results.
Performing sorting, clonal expansion, and conventional sequencing of cDNA is a labourious process that is impractical for routine use. However, at this early stage of assay development it is necessary to demonstrate that the assay detects actual mutations with the appropriate chemical-specific spectral signature. NGS may provide a more rapid approach for characterising the spectra of induced mutations. For proof of principle, we performed unidirectional sequencing on a Roche 454 GS Junior system to simultaneously detect mutant sequences in a pool of PCR-amplified Pig-a cDNA from 64 clones that potentially contained up to 256 mutants (64 wells × 4 CD48-deficient sorted lymphocytes per well). In unidirectional sequencing, DNA fragments are sequenced in one direction. While it is less accurate than bidirectional sequencing, it appears to be well-suited for the quick identification of a mutation spectrum as it provides the necessary accuracy to simultaneously detect up to several dozen mutations. Comparing the results generated by NGS with those determined by Sanger sequencing in the same clones, NGS identified most (i.e. ~82%; 33 out of 40) of the mutations determined by the clone-by-clone approach and found several additional, potentially legitimate mutations.
However, with an error rate close to 1%, our NGS approach also generated significant 'noise'. Irrelevant base alterations were scored a limited number of times (<1% threshold), while the 'true' mutations (confirmed with Sanger sequencing) were scored more often (>1%). Establishing the threshold for distinguishing legitimate mutation from background noise may be challenging. Besides the sequencing error rate, the threshold may be influenced by the number of different mutations present in the mixture. However, once the appropriate detection criteria have been determined, the NGS approach is capable of rapidly providing relevant information on mutational spectra (see Table II ). There are several other NGS techniques, such as bidirectional sequencing and molecular tagging, that have significantly lower error rates, and these should be explored for their applicability to the Pig-a assay. However, with some improvements, the NGS methodology we employed in this study potentially can detect a reasonable number of mutations (perhaps fewer than 100 mutations) in a pool of sorted mutant cells even without clonal expansion.
In conclusion, we have demonstrated that CD48-deficient lymphocytes derived from ENU-treated rats contain DNA mutations in the Pig-a gene having a characteristic ENU spectrum. This observation supports the hypothesis that various flow cytometry-based Pig-a assays (including RBC Pig-a assays) detect true mutation. To further support the link between marker deficiency and Pig-a mutation, similar studies could be performed with untreated animals (to determine the spectrum of spontaneous Pig-a mutation) and with animals exposed to compounds having different spectra of mutation, e.g. benzo[a]pyrene, which induces mutations predominantly at G:C base pairs) (17) .
Supplementary data
Supplementary Table I is available at Mutagenesis Online.
